| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068965638 |
| P356 | DOI | 10.2119/MOLMED.2013.00140 |
| P932 | PMC publication ID | 3883962 |
| P698 | PubMed publication ID | 24408112 |
| P50 | author | Philippe Marambaud | Q30420124 |
| Valérie Vingtdeux | Q30421269 | ||
| P2093 | author name string | Peter Davies | |
| Cristina d'Abramo | |||
| Rachel Friedman | |||
| Jeremy Koppel | |||
| Heidy Jimenez | |||
| Mark Stauber | |||
| P2860 | cites work | Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation | Q21245246 |
| Microglia and neuroinflammation: a pathological perspective | Q24799838 | ||
| Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways | Q26830542 | ||
| Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model | Q28115206 | ||
| Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains | Q28189423 | ||
| Microglia-specific localisation of a novel calcium binding protein, Iba1 | Q28273977 | ||
| Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway | Q28571359 | ||
| High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation | Q29616564 | ||
| Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. | Q51774412 | ||
| Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells | Q61479730 | ||
| Marijuana, immunity and infection | Q74608042 | ||
| Techniques of image analysis for quantitative immunohistochemistry | Q81243040 | ||
| Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. | Q30506148 | ||
| Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. | Q31840691 | ||
| AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. | Q33726605 | ||
| Targeting the endocannabinoid system in Alzheimer's disease. | Q33930000 | ||
| LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice | Q34173381 | ||
| Alzheimer's disease in man and transgenic mice: females at higher risk | Q34174531 | ||
| Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease | Q34312272 | ||
| Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. | Q34397288 | ||
| {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE. | Q34635580 | ||
| Attenuation of allergic contact dermatitis through the endocannabinoid system | Q34635629 | ||
| Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease | Q35167904 | ||
| Microglia and Alzheimer's disease pathogenesis | Q35805628 | ||
| Cannabinoid-based drugs as anti-inflammatory therapeutics | Q36111923 | ||
| Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models | Q36328476 | ||
| The peripheral cannabinoid receptor knockout mice: an update | Q36416347 | ||
| Targeting the CB2 receptor for immune modulation | Q36596663 | ||
| Heterogeneity of CNS myeloid cells and their roles in neurodegeneration | Q37939514 | ||
| Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology | Q38061480 | ||
| Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease | Q38294479 | ||
| Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies | Q41612685 | ||
| Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. | Q43266820 | ||
| CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients | Q43460178 | ||
| Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor | Q43503403 | ||
| CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice. | Q44094824 | ||
| Inflammation occurs early during the Abeta deposition process in TgCRND8 mice | Q44948592 | ||
| Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome | Q45007178 | ||
| Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease | Q45111716 | ||
| Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. | Q46303283 | ||
| Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles | Q46332461 | ||
| Abnormal processing of tau in the brain of aged TgCRND8 mice. | Q48094292 | ||
| The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging | Q48156883 | ||
| Activation of the CB2 receptor system reverses amyloid-induced memory deficiency | Q48440561 | ||
| Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease | Q48656375 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 357-364 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease | |
| P478 | volume | 19 |
| Q26746050 | CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease |
| Q35667387 | Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation |
| Q38748394 | Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? |
| Q38593120 | Genetic Manipulation of the Endocannabinoid System |
| Q38395251 | New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds |
| Q92719134 | Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists |
Search more.